Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 19, 2014
Nearly pain-free self-administration of subcutaneous methotrexate with an autoinjector: results of a phase 2 clinical trial in patients with rheumatoid arthritis who have functional limitationsBruce Freundlich, Alan Kivitz, Jonathan S JaffeThe Journal of Sexual Medicine|September 26, 2019
Safety of a New Subcutaneous Testosterone Enanthate Auto-Injector: Results of a 26-Week StudyMarc Gittelman, Jonathan S Jaffe, Jed C KaminetskyAnnals of the Rheumatic Diseases|April 15, 2014
Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administrationMichael H Schiff, Jonathan S Jaffe, Bruce FreundlichSexual Medicine|January 23, 2016
Pharmacokinetic Profile of Subcutaneous Testosterone Enanthate Delivered via a Novel, Prefilled Single-Use Autoinjector: A Phase II StudyJed Kaminetsky, Jonathan S Jaffe, Ronald S SwerdloffJournal of the Endocrine Society|May 14, 2023
Allometric Scaling of Testosterone Enanthate Pharmacokinetics to Adolescent Hypogonadal Males (IM and SC Administration)Maria G Vogiatzi, Jonathan S Jaffe, Takugo Amy, et al.The Journal of Sexual Medicine|November 6, 2018
Summative Usability Evaluation of the SCTE-AI Device: A Novel Prefilled Autoinjector for Subcutaneous Testosterone AdministrationSamir Arora, Betsy Moclair, Kyle Murphy, et al.Journal of the Endocrine Society|December 9, 2020
Testosterone Use in Adolescent Males: Current Practice and Unmet NeedsMaria Vogiatzi, James P Tursi, Jonathan S Jaffe, et al.The Journal of Urology|October 9, 2018
A 52-Week Study of Dose Adjusted Subcutaneous Testosterone Enanthate in Oil Self-Administered via Disposable Auto-InjectorJed C Kaminetsky, Andrew McCullough, Kathleen Hwang, et al.Andrology|September 12, 2021
Pharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men ageAlexander W Pastuszak, Marc Gittelman, James P Tursi, et al.Pageof 1